stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Lakewood Amedex Biotherapeutics IncLABT
$0.244915.03%0.032

Lakewood Amedex Biotherapeutics Inc (LABT)

Lakewood Amedex Biotherapeutics Inc Stock (LABT) Forecast

The Lakewood Amedex Biotherapeutics Inc (LABT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $42.95, representing a +17,440% increase from the current price of $0.2449. The highest analyst price target is $48.15, and the lowest is $37.76.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month LABT Price Target
Average 58.11 (+23,630% Upside)

Is Lakewood Amedex Biotherapeutics Inc (LABT) A Buy Now?

Oscillators
NameValueAction
RSI(14)35.81Neutral
STOCH(9,6)11.30Buy
STOCHRSI(14)68.40Neutral
MACD(12,26)-0.15Buy
ADX(14)27.81Buy
William %R-90.65Buy
CCI(14)-39.88Neutral
Buy: 4 · Sell: 0 · Neutral: 3Summary: Buy
Moving Averages
PeriodSimpleExponential
MA10
0.30
Sell
0.27
Sell
MA20
0.29
Sell
0.36
Sell
MA50
0.80
Sell
1.04
Sell
MA100
1.56
Sell
3.94
Sell
MA200
4.83
Sell
0.00
Buy
Buy: 1 · Sell: 9 · Neutral: 0Summary: Sell

According to our latest analysis, LABT could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 9 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on LABT, as trading bearish markets can be challenging and may result in losses.

  1. RSI (Relative Strength Index): The RSI(14) value of 35.81 indicates that LABT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 11.30 indicates that LABT is oversold. This indicates that LABT price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 68.40 indicates that LABT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of 27.81 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of -39.88 indicates that LABT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term LABT price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Lakewood Amedex Biotherapeutics Inc financial reports and earnings history, Lakewood Amedex Biotherapeutics Inc (LABT) stock could reach $437.83 by 2030, $1,514.12 by 2040 and $2,540.14 by 2050. See the projected annual prices until 2050 of the Lakewood Amedex Biotherapeutics Inc stock below:

  • Lakewood Amedex Biotherapeutics Inc (LABT) is expected to reach an average price of $439.12 in 2035, with a high prediction of $936.22 and a low estimate of $29.71. This indicates an +179.21K% change from the last recorded price of $0.2449.
  • Lakewood Amedex Biotherapeutics Inc (LABT) stock is projected to chart a bullish course in 2040, with an average price target of $1,539.78, representing an +628.64K% change from its current level. The forecast ranges from a conservative $45.81 to a sky-high $1,514.12.
  • Our analysts predict Lakewood Amedex Biotherapeutics Inc (LABT) to change +471.33K% by 2045, soaring from $64.21 to an average price of $1,154.54, potentially reaching $2,027.13. While $64.21 is the low estimate, the potential upside is significant.
  • Lakewood Amedex Biotherapeutics Inc (LABT) stock is expected to climb by 2050, reaching an average of $232.74, a +94,936% change from its current level. However, a wide range of estimates exists, with high and low targets of $2,540.14 and $80.31, respectively, highlighting the market's uncertainty.

Lakewood Amedex Biotherapeutics Inc Stock (LABT) Year by Year Forecast

Lakewood Amedex Biotherapeutics Inc Stock (LABT) Price Forecast for 2026

The predicted value for Lakewood Amedex Biotherapeutics Inc (LABT) in 2026 is set at an average of $15.84. Estimates vary from a peak of $98.20 to a trough of $0.1687, indicating an +6,367% surge from the present price of $0.2449.

MonthAverageLowHighChange from today's price
December, 2026$55.78$37.76$48.15+22,677%

Lakewood Amedex Biotherapeutics Inc Stock (LABT) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Lakewood Amedex Biotherapeutics Inc (LABT) is $57.16, with a high forecast of $114.12 and a low forecast of $2.11. This indicates an +23,240% increase from the last price of $0.2449.

MonthAverageLowHighChange from today's price
January, 2027$50.64$50.47$53.36+20,576%
February, 2027$43.54$44.05$47.69+17,677%
March, 2027$33.44$33.64$41.14+13,553%
April, 2027$25.47$25.49$31.27+10,302%
May, 2027$15.98$16.01$22.66+6,426%
June, 2027$8.36$8.37$13.93+3,315%
July, 2027$73.07$2.11$48.37+29,738%
August, 2027$118.63$106.35$111.00+48,340%
September, 2027$105.13$105.33$114.12+42,828%
October, 2027$89.68$90.19$100.10+36,519%
November, 2027$69.14$69.34$85.19+28,133%
December, 2027$52.83$52.85$64.89+21,472%

Lakewood Amedex Biotherapeutics Inc Stock (LABT) Price Forecast for 2028

In 2028, Lakewood Amedex Biotherapeutics Inc (LABT) is projected to reach an average price of $116.87, with a high projection of $234.09 and a low estimate of $4.41. This indicates an +47,621% rise from the last price of $0.2449.

MonthAverageLowHighChange from today's price
January, 2028$32.90$32.92$47.92+13,333%
February, 2028$16.93$16.93$28.75+6,812%
March, 2028$146.36$4.41$121.66+59,664%
April, 2028$179.81$173.37$167.07+73,321%
May, 2028$159.63$159.83$174.88+65,081%
June, 2028$135.83$136.34$152.51+55,361%
July, 2028$104.85$105.05$129.25+42,712%
August, 2028$80.18$80.20$98.50+32,641%
September, 2028$56.05$56.09$73.19+22,788%
October, 2028$25.49$25.50$49.79+10,309%
November, 2028$219.65$6.71$194.95+89,589%
December, 2028$244.74$240.39$234.09+99,836%

Lakewood Amedex Biotherapeutics Inc Stock (LABT) Price Forecast for 2029

The 2029 price forecast for Lakewood Amedex Biotherapeutics Inc Stock (LABT) is $183.13 on average, with a high prediction of $301.12 and a low estimate of $9.01. This represents an +74,677% increase from the previous price of $0.2449.

MonthAverageLowHighChange from today's price
January, 2029$214.12$214.33$236.69+87,334%
February, 2029$181.97$182.48$204.91+74,204%
March, 2029$148.95$149.22$173.31+60,723%
April, 2029$107.54$107.56$140.36+43,811%
May, 2029$75.06$75.09$98.46+30,548%
June, 2029$42.30$42.32$66.70+17,171%
July, 2029$292.94$9.01$268.24+119.51K%
August, 2029$309.68$307.42$301.12+126.35K%
September, 2029$275.25$276.81$299.54+112.29K%
October, 2029$228.12$228.63$264.78+93,046%
November, 2029$186.75$187.02$217.37+76,155%
December, 2029$134.89$134.91$176.07+54,980%

Lakewood Amedex Biotherapeutics Inc Stock (LABT) Price Forecast for 2030

Lakewood Amedex Biotherapeutics Inc Stock (LABT) is expected to reach an average price of $181.66 in 2030, with a high forecast of $437.83 and a low forecast of $11.31. This signifies an +74,076% surge from the last price of $0.2449.

MonthAverageLowHighChange from today's price
January, 2030$94.06$94.09$123.72+38,307%
February, 2030$52.95$52.97$83.62+21,520%
March, 2030$11.29$11.31$42.52+4,509%
April, 2030$374.61$374.44$368.57+152.87K%
May, 2030$331.83$333.40$362.39+135.40K%
June, 2030$286.65$286.79$319.28+116.95K%
July, 2030$224.54$224.81$273.77+91,587%
August, 2030$174.15$174.43$211.77+71,012%
September, 2030$113.06$113.10$161.27+46,067%
October, 2030$63.60$63.63$100.54+25,869%
November, 2030$13.59$13.61$51.09+5,448%
December, 2030$439.55$440.45$437.83+179.38K%

Similar to LABT